Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large-Scale Collaborative Assessment of Binding Free Energy Calculations for Drug Discovery Using OpenFE.

Journal of chemical information and modeling·2026
Same author

Discovery of 5‑Azaindole Inhibitors of O‑GlcNAcase for the Treatment of Alzheimer's Disease and Related Tauopathies.

ACS medicinal chemistry letters·2026
Same author

REINFORCE-ING Chemical Language Models for Drug Discovery.

Journal of chemical information and modeling·2025
Same author

C2PO: an ML-powered optimizer of the membrane permeability of cyclic peptides through chemical modification.

Journal of cheminformatics·2025
Same author

MolAgent: Biomolecular Property Estimation in the Agentic Era.

Journal of chemical information and modeling·2025
Same author

Spatio-temporal learning from molecular dynamics simulations for protein-ligand binding affinity prediction.

Bioinformatics (Oxford, England)·2025

Related Experiment Video

Updated: Jun 3, 2026

Modeling Ligands into Maps Derived from Electron Cryomicroscopy
09:30

Modeling Ligands into Maps Derived from Electron Cryomicroscopy

Published on: July 19, 2024

Modeling approaches for ligand-based 3D similarity.

Gary Tresadern1, Daniele Bemporad

  • 1Johnson & Johnson Pharmaceutical Research & Development, Janssen-Cilag S A, Calle Jarama 75, Poligono Industrial, 45007 Toledo, Spain. gtresade@its.jnj.com

Future Medicinal Chemistry
|March 24, 2011
PubMed
Summary

3D ligand similarity methods accelerate drug discovery by enabling faster virtual screening and compound design. This review guides medicinal chemists through available software, enhancing efficiency in preclinical research.

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Related Experiment Videos

Last Updated: Jun 3, 2026

Modeling Ligands into Maps Derived from Electron Cryomicroscopy
09:30

Modeling Ligands into Maps Derived from Electron Cryomicroscopy

Published on: July 19, 2024

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Area of Science:

  • Computational chemistry
  • Drug discovery and development
  • Medicinal chemistry

Background:

  • 3D ligand-based similarity approaches are crucial in early drug discovery for virtual screening and quantitative structure-activity relationship (QSAR) modeling.
  • Historically, these methods required expert users but have seen improved usability and speed, enabling large-scale database screening.
  • The increasing complexity and number of available tools can be daunting for the medicinal chemistry community.

Purpose of the Study:

  • To review widely used software for 3D ligand-based similarity tasks.
  • To provide background on the underlying theory of these computational methods.
  • To offer practical examples for researchers in drug discovery.

Main Methods:

  • Review of computational software for 3D ligand-based similarity.
  • Explanation of theoretical underpinnings of shape-based and other similarity techniques.
  • Application-based examples and case studies.

Main Results:

  • Advances in software have made 3D similarity methods more accessible and efficient.
  • These methods are increasingly impacting drug discovery projects, aiding in hit identification and compound design.
  • A wide array of tools exists, each with specific strengths for different applications.

Conclusions:

  • 3D ligand similarity computational approaches are essential for efficient preclinical drug discovery.
  • Understanding the nuances of different methods is key to selecting the appropriate tool.
  • These techniques will play a growing role in accelerating the drug development pipeline.